Referral patterns of GIST patients: data from a nationwide study
CONCLUSION: A substantial amount of metastatic GIST patients in non-reference centers did not receive systemic treatment. This might be due to valid reasons. However, optimisation of the referral strategy of GIST patients in the Netherlands could benefit patients. Further research is needed to explore reasons for not starting systemic treatment in metastatic GIST patients.PMID:38353407 | DOI:10.2340/1651-226X.2024.23722 (Source: Acta Oncologica)
Source: Acta Oncologica - February 14, 2024 Category: Cancer & Oncology Authors: Evelyne Roets Nikki S Ijzerman Vincent K Y Ho Ingrid M E Desar Anna K L Reyners Hans Gelderblom Dirk J Gr ünhagen Boudewijn Van Etten Winan J Van Houdt Winette T A Van der Graaf Neeltje Steeghs Source Type: research
Referral patterns of GIST patients: data from a nationwide study
CONCLUSION: A substantial amount of metastatic GIST patients in non-reference centers did not receive systemic treatment. This might be due to valid reasons. However, optimisation of the referral strategy of GIST patients in the Netherlands could benefit patients. Further research is needed to explore reasons for not starting systemic treatment in metastatic GIST patients.PMID:38353407 | DOI:10.2340/1651-226X.2024.23722 (Source: Acta Oncologica)
Source: Acta Oncologica - February 14, 2024 Category: Cancer & Oncology Authors: Evelyne Roets Nikki S Ijzerman Vincent K Y Ho Ingrid M E Desar Anna K L Reyners Hans Gelderblom Dirk J Gr ünhagen Boudewijn Van Etten Winan J Van Houdt Winette T A Van der Graaf Neeltje Steeghs Source Type: research
Referral patterns of GIST patients: data from a nationwide study
CONCLUSION: A substantial amount of metastatic GIST patients in non-reference centers did not receive systemic treatment. This might be due to valid reasons. However, optimisation of the referral strategy of GIST patients in the Netherlands could benefit patients. Further research is needed to explore reasons for not starting systemic treatment in metastatic GIST patients.PMID:38353407 | DOI:10.2340/1651-226X.2024.23722 (Source: Acta Oncologica)
Source: Acta Oncologica - February 14, 2024 Category: Cancer & Oncology Authors: Evelyne Roets Nikki S Ijzerman Vincent K Y Ho Ingrid M E Desar Anna K L Reyners Hans Gelderblom Dirk J Gr ünhagen Boudewijn Van Etten Winan J Van Houdt Winette T A Van der Graaf Neeltje Steeghs Source Type: research
Referral patterns of GIST patients: data from a nationwide study
CONCLUSION: A substantial amount of metastatic GIST patients in non-reference centers did not receive systemic treatment. This might be due to valid reasons. However, optimisation of the referral strategy of GIST patients in the Netherlands could benefit patients. Further research is needed to explore reasons for not starting systemic treatment in metastatic GIST patients.PMID:38353407 | DOI:10.2340/1651-226X.2024.23722 (Source: Acta Oncologica)
Source: Acta Oncologica - February 14, 2024 Category: Cancer & Oncology Authors: Evelyne Roets Nikki S Ijzerman Vincent K Y Ho Ingrid M E Desar Anna K L Reyners Hans Gelderblom Dirk J Gr ünhagen Boudewijn Van Etten Winan J Van Houdt Winette T A Van der Graaf Neeltje Steeghs Source Type: research
Referral patterns of GIST patients: data from a nationwide study
CONCLUSION: A substantial amount of metastatic GIST patients in non-reference centers did not receive systemic treatment. This might be due to valid reasons. However, optimisation of the referral strategy of GIST patients in the Netherlands could benefit patients. Further research is needed to explore reasons for not starting systemic treatment in metastatic GIST patients.PMID:38353407 | DOI:10.2340/1651-226X.2024.23722 (Source: Acta Oncologica)
Source: Acta Oncologica - February 14, 2024 Category: Cancer & Oncology Authors: Evelyne Roets Nikki S Ijzerman Vincent K Y Ho Ingrid M E Desar Anna K L Reyners Hans Gelderblom Dirk J Gr ünhagen Boudewijn Van Etten Winan J Van Houdt Winette T A Van der Graaf Neeltje Steeghs Source Type: research
Methylphenidate for treating fatigue in palliative cancer care - effect and side effects in real-world data from a palliative care unit
CONCLUSION: Methylphenidate is generally effective and well-tolerated for the treatment of CRF in palliative care. However, patients with a short life expectancy (<4 weeks) seem to benefit less from the treatment regardless of age, cancer type and dose.PMID:38348853 | DOI:10.2340/1651-226X.2024.24156 (Source: Acta Oncologica)
Source: Acta Oncologica - February 13, 2024 Category: Cancer & Oncology Authors: Agneta Almerud Gabriella Frisk Caritha Klasson Linda Bj örkhem-Bergman Source Type: research
Blood sampling patterns in primary care change several years before a cancer diagnosis
Acta Oncol. 2024 Feb 13;63:17-22. doi: 10.2340/1651-226X.2024.28559.NO ABSTRACTPMID:38349122 | DOI:10.2340/1651-226X.2024.28559 (Source: Acta Oncologica)
Source: Acta Oncologica - February 13, 2024 Category: Cancer & Oncology Authors: Mathilde Egelund Christensen Mia Klinten Grand Margit Kriegbaum Bent Struer Lind Kirsten Gr ønbæk Frederik Persson Christoffer Johansen Christen Lykkegaard Andersen Source Type: research
Evaluation of in vitro irradiation setup: Designed for the horizontal beamline at the Danish Centre for Particle Therapy
CONCLUSION: Cell survival curves could be produced with acceptable uncertainties using this novel water phantom and cellular laboratory workflow. The setup is useful for future in vitro irradiation experiments.PMID:38349282 | DOI:10.2340/1651-226X.2024.19657 (Source: Acta Oncologica)
Source: Acta Oncologica - February 13, 2024 Category: Cancer & Oncology Authors: Anders Tobias Frederiksen Morten Bj ørn Jensen Per Rugaard Poulsen Niels Bassler Brita Singers S ørensen Mateusz Sitarz Source Type: research
Childhood cancer incidence and survival in the Faroe Islands, 1960 to 2019
CONCLUSION: Childhood cancer in the Faroes was slightly rarer than in most other high-income countries. Brain and spinal tumors were the most common cancer group in Faroese children. Survival for Faroese children with cancer has improved substantially in the study period.PMID:38332589 | DOI:10.2340/1651-226X.2024.27110 (Source: Acta Oncologica)
Source: Acta Oncologica - February 9, 2024 Category: Cancer & Oncology Authors: Marnar Fr íðheim Kristiansen Elmar Ósá Lisa Lyngsie Hjalgrim Bjarni Á Steig Gu ðrið Andórsdóttir Marin Str øm Maria Skaalum Petersen Source Type: research
Turning the page on 2024 - embracing Open Science
Acta Oncol. 2024 Jan 16;63:1-2. doi: 10.2340/1651-226X.2024.25815.NO ABSTRACTPMID:38226851 | DOI:10.2340/1651-226X.2024.25815 (Source: Acta Oncologica)
Source: Acta Oncologica - January 16, 2024 Category: Cancer & Oncology Authors: Mef Nilbert Source Type: research
Overall survival in 92,991 colorectal cancer patients in Germany: differences according to type of comorbidity
CONCLUSIONS: Our results suggest that patients with CRC and with mental comorbidities, particularly males, have a markedly lower overall survival compared to those without any or only somatic comorbidities.PMID:37975622 | DOI:10.1080/0284186X.2023.2282120 (Source: Acta Oncologica)
Source: Acta Oncologica - November 17, 2023 Category: Cancer & Oncology Authors: Oliver Riedel Jost Viebrock Ulrike Haug Source Type: research
Overall survival in 92,991 colorectal cancer patients in Germany: differences according to type of comorbidity
CONCLUSIONS: Our results suggest that patients with CRC and with mental comorbidities, particularly males, have a markedly lower overall survival compared to those without any or only somatic comorbidities.PMID:37975622 | DOI:10.1080/0284186X.2023.2282120 (Source: Acta Oncologica)
Source: Acta Oncologica - November 17, 2023 Category: Cancer & Oncology Authors: Oliver Riedel Jost Viebrock Ulrike Haug Source Type: research
Overall survival in 92,991 colorectal cancer patients in Germany: differences according to type of comorbidity
CONCLUSIONS: Our results suggest that patients with CRC and with mental comorbidities, particularly males, have a markedly lower overall survival compared to those without any or only somatic comorbidities.PMID:37975622 | DOI:10.1080/0284186X.2023.2282120 (Source: Acta Oncologica)
Source: Acta Oncologica - November 17, 2023 Category: Cancer & Oncology Authors: Oliver Riedel Jost Viebrock Ulrike Haug Source Type: research
Overall survival in 92,991 colorectal cancer patients in Germany: differences according to type of comorbidity
CONCLUSIONS: Our results suggest that patients with CRC and with mental comorbidities, particularly males, have a markedly lower overall survival compared to those without any or only somatic comorbidities.PMID:37975622 | DOI:10.1080/0284186X.2023.2282120 (Source: Acta Oncologica)
Source: Acta Oncologica - November 17, 2023 Category: Cancer & Oncology Authors: Oliver Riedel Jost Viebrock Ulrike Haug Source Type: research
Overall survival in 92,991 colorectal cancer patients in Germany: differences according to type of comorbidity
CONCLUSIONS: Our results suggest that patients with CRC and with mental comorbidities, particularly males, have a markedly lower overall survival compared to those without any or only somatic comorbidities.PMID:37975622 | DOI:10.1080/0284186X.2023.2282120 (Source: Acta Oncologica)
Source: Acta Oncologica - November 17, 2023 Category: Cancer & Oncology Authors: Oliver Riedel Jost Viebrock Ulrike Haug Source Type: research
